Halozyme Therapeutics Inc (HALO)

10:31 AM

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View - TradingView

10:31 AM

08:54 AM

HALO Receives Maintained Rating and Raised Price Target by Citiz - GuruFocus

08:54 AM

06:35 AM

Citizens raises Halozyme Therapeutics stock price target to $92 on strong royalty growth - Investing.com Nigeria

06:35 AM

06:30 AM

Hussman Strategic Advisors Inc. Grows Stock Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat

06:30 AM

05:16 AM

Halozyme Therapeutics: Q3 Earnings Snapshot - New Haven Register

05:16 AM

04:58 AM

Is Halozyme Therapeutics Inc. (RV7) stock dividend growth reliableWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - newser.com

04:58 AM

02:46 AM

Halozyme Rides Strong Royalty Growth To Lift Its Outlook - Finimize

02:46 AM

01:26 AM

Halozyme Q3 2025 slides: royalty revenue surges 52%, guidance raised on strong growth By Investing.com - Investing.com South Africa

01:26 AM

12:23 PM

Decoding Halozyme Therapeutics Inc (HALO): A Strategic SWOT Insi - GuruFocus

12:23 PM

12:09 PM

Decoding Halozyme Therapeutics Inc (HALO): A Strategic SWOT Insight - GuruFocus

12:09 PM

12:01 PM

Halozyme Therapeutics Inc (HALO) Q3 2025 Earnings Call Highlights: Record Royalty Revenue and ... - Yahoo! Finance UK

12:01 PM

Nov 03, 2025

Halozyme Q3 2025 slides: royalty revenue surges 52%, guidance raised on strong growth - Investing.com Australia

Nov 03, 2025

Nov 03, 2025

Using Python tools to backtest Halozyme Therapeutics Inc. strategies2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Why Halozyme Therapeutics Inc. stock is in analyst buy zoneDividend Hike & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Halozyme Therapeutics (HALO) Reports Record Q3 Revenue Growth - GuruFocus

Nov 03, 2025

Nov 03, 2025

Transcript : Halozyme Therapeutics, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Earnings call transcript: Halozyme Q3 2025 beats earnings expectations By Investing.com - Investing.com Nigeria

Nov 03, 2025

Nov 03, 2025

Halozyme Therapeutics (HALO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Nov 03, 2025

Nov 03, 2025

Halozyme (HALO) Q3 2025 Earnings Call Transcript - AOL.com

Nov 03, 2025

Nov 03, 2025

Earnings call transcript: Halozyme Q3 2025 beats earnings expectations - Investing.com

Nov 03, 2025

Nov 03, 2025

Halozyme Therapeutics (HALO) Beats Q3 Earnings and Revenue Estimates - Yahoo! Finance Australia

Nov 03, 2025

Nov 03, 2025

HALO Boosts 2025 Revenue Forecast Amid Strong Earnings Outlook - GuruFocus

Nov 03, 2025

Nov 03, 2025

Halozyme Raises 2025 Guidance After Strong Q3 Results - TipRanks

Nov 03, 2025

Nov 03, 2025

Halozyme Therapeutics, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq

Nov 03, 2025

Nov 03, 2025

HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS - PR Newswire

Nov 03, 2025

Nov 03, 2025

Can Halozyme Therapeutics Inc. stock continue upward trendJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

What insider trading reveals about Halozyme Therapeutics Inc. stockTrade Entry Report & Entry Point Strategy Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Strategies to average down on Halozyme Therapeutics Inc.Market Trend Report & Verified Stock Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Tools to assess Halozyme Therapeutics Inc.’s risk profileJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Exit strategy if you’re trapped in Halozyme Therapeutics Inc.Exit Point & AI Powered Buy/Sell Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Will Halozyme Therapeutics Inc. (RV7) stock outperform global peersPortfolio Update Summary & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

How Halozyme Therapeutics Inc. (RV7) stock behaves in tightening cyclesDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Torray Investment Partners LLC Has $2.08 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat

Nov 03, 2025

Nov 03, 2025

How Halozyme Therapeutics Inc. (RV7) stock reacts to stronger dollarBreakout Watch & AI Based Buy/Sell Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Why Halozyme Therapeutics Inc. stock could be next big winner2025 Momentum Check & Safe Capital Preservation Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Assetmark Inc. Raises Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat

Nov 03, 2025

Nov 03, 2025

Arkadios Wealth Advisors Acquires 11,457 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat

Nov 03, 2025

Nov 03, 2025

Will Halozyme Therapeutics Inc. stock benefit from infrastructure spendingIPO Watch & Risk Managed Investment Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Will Halozyme Therapeutics Inc. price bounce be sustainableJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Will Halozyme Therapeutics Inc. stock benefit from upcoming earnings reportsQuarterly Portfolio Review & AI Driven Price Predictions - newser.com

Nov 03, 2025

Nov 02, 2025

Halozyme Therapeutics (HALO) Anticipates Strong Q3 Earnings Grow - GuruFocus

Nov 02, 2025

Nov 02, 2025

Will Halozyme Therapeutics Inc. stock see PE expansionMarket Activity Report & High Accuracy Investment Signals - newser.com

Nov 02, 2025

Nov 02, 2025

Combining price and volume data for Halozyme Therapeutics Inc.2025 Price Targets & Low Risk Entry Point Tips - newser.com

Nov 02, 2025

Nov 02, 2025

Retirement Systems of Alabama Sells 4,246 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat

Nov 02, 2025

Nov 02, 2025

AlphaQuest LLC Purchases 5,133 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat

Nov 02, 2025

Nov 01, 2025

HALOZYME THERAPEUTICS Earnings Preview: Recent $HALO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Nov 01, 2025